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NM23-H1 and NM23-H2 are neighboring genes on chromosome 17q. They encode nucleoside diphosphate kinases that have additional roles in
signal transduction, transcription, and apoptosis. NM23-H1 expression is a strong marker for prognosis and metastatic behavior in many tumor
types. A new bioinformatic tool, TranscriptView, identified read-through transcripts that start in the NM23-H1 gene and continue in the
neighboring NM23-H2 gene. Splicing results in a transcript containing exons 1 to 4 of NM23-H1 and exons 2 to 5 of NM23-H2. The resulting
mRNA encodes a novel and long variant of the NM23 protein family, NM23-LV, which contains part of NM23-H1 and the complete NM23-H2
protein. The transcript was amplified and sequenced from two neuroblastoma cell lines, confirming the presence of the predicted NM23-LV mRNA
in vivo. Tissue analysis showed that NM23-LV is ubiquitously expressed, with the exception of the kidney. Neuroblastoma tumors show high-level
expression of NM23-H1 and-H2 as well as NM23-LV mRNA. In neuroblastoma cells, the NM23-LV protein has mainly a cytoplasmic localization,
but some nuclear staining was observed as well.
© 2005 Elsevier Inc. All rights reserved.Keywords: NM23; NM23-LV; Read-through transcript; Alternative splicing; NeuroblastomaIntroduction
The NM23 (NME/NDPK) gene family consists of eight
genes, of which NM23-H1 and-H2 are the most studied
members [1]. These two genes encode nucleoside diphosphate
kinases (NDPK). In homohexamer or heterohexamer confor-
mation, they are responsible for the maintenance of the
nucleoside triphosphate pool in the cell.
Reduced expression of NM23-H1 is correlated with aggres-
sive forms of melanoma, breast cancer, and gastric cancer [2–5].
Transfection of NM23-H1 resulted in reduced metastatic
potential of melanoma, breast carcinoma, and prostate carcino-
ma cell lines [6–8]. However, in another group of tumors, high
NM23-H1 expression is correlated with aggressive tumor
behavior. High expression of NM23-H1 and NM23-H2 corre-
lates with poor prognosis in neuroblastoma [9], lung tumors☆ Sequence data from this article have been deposited with the GenBank Data
Library under Accession No. DQ109675.
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doi:10.1016/j.ygeno.2005.11.004[10], and thyroid carcinoma [11]. The NM23-H1 and NM23-H2
genes are transcriptionally up-regulated by the N-myc oncogene,
which is amplified in a subset of neuroblastoma tumors [12]. In
addition, extra copies of the chromosome 17q region encoding
the NM23-H1 and-H2 genes are present in the majority of
neuroblastoma tumors [13,14]. Therefore, neuroblastomas with
N-myc amplification and gain of chromosome 17q have very
high NM23-H1 and-H2 levels. There is accumulating evidence
that the role of NM23-H1 and-H2 in cancer is not mediated by
the nucleotide diphosphate kinase function. Mutant NM23-H1
genes that are no longer catalytically active for NDPK function
still can revert the metastatic potential of tumor cells [8].
Indeed, the NM23-H1 and-H2 proteins have been found to
play a role in regulating cell shape and differentiation,
transcription, and apoptosis. The G-proteins Rac1, Rad, and
Cdc42 are involved in reorganization of the cytoskeleton.
NM23-H1 interacts directly with Rad and induces GDP/GTP
exchange [15]. Indirectly, NM23-H1 inactivates Rac1 by
sequestration of Tiam1 [16]. NM23-H1 also interacts with
Cdc42 and thereby inhibits the neuronal differentiation of
neuroblastoma cells [17]. In addition to these signaling
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components and the centrosome has been observed. NM23-H1
interacts with β-tubulin [18], vimentin [19], and γ-tubulin [20].
NM23-H2 has also been shown to be involved in cell signaling.
During early stages of cell spreading, NM23-H2 interacts with
integrin cytoplasmic domain-associated protein ICAP-1α,
which is essential for cell adhesion [21]. Finally, the NM23-
H1 protein was found to interact with the PRUNE protein [22].
Mutants of the Drosophila NM23 homologue (awd) and Prune
together cause developmental defects [23].
Recently, NM23-H1 was identified as part of the Granzym
A-activated complex in cytotoxic T lymphocytes [24]. The
complex is translocated to the nucleus, where NM23-H1
induces DNA breaks, leading to apoptosis. Nuclear NM23-H2
is involved in transcriptional regulation. NM23-H2 was
proposed to regulate the expression of c-myc, PDGF-A, and
gelatinase A [25–27].
Here we describe a novel mRNA transcript that consists of
both NM23-H1 and NM23-H2 sequences. It starts in NM23-H1
and then reads through into the neighboring NM23-H2 gene.
The novel transcript, called NM23-LV, is ubiquitously expressed
and encodes a protein consisting of the major part of the NM23-
H1 amino acids and all of the NM23-H2 amino acids.
Results
TranscriptView identifies a novel transcript NM23LV
TranscriptView (http://bioinfo.amc.uva.nl/human-genetics/
transcriptview/) is a new bioinformatic genome browser that
displays EST and mRNA sequences aligned along the genome
sequence (J. Koster et al., manuscript in prep.). Fig. 1A shows
the alignment of 1473 ESTs and mRNAs of NM23-H1 and
NM23-H2 along the genomic sequence. Clearly, most NM23-
H1 transcripts cluster together, apart from the NM23-H2
transcripts. The NM23-H1 cluster (Fig. 1A, left) consists of
654 transcripts, whereas the NM23-H2 cluster (Fig. 1A, right)
includes 789 transcripts. The NM23-H1B transcript with an
alternative start site [28] is represented by several ESTs (Figs.
1A and 1B). In addition to these previously described NM23
transcripts, 30 EST sequences map to both NM23-H1 and
NM23-H2 genomic sequences. All 30 ESTs lack exon 5 of
NM23-H1, which contains the stop codon. In addition, they all
lack exon 1 of NM23-H2, which is an untranslated sequence.
Thus, these 30 transcripts represent a novel mRNA, which we
named NM23-LV (long variant, GenBank Accession No.
DQ109675). The predicted NM23-LVmRNA sequence encodes
a putative novel protein with part of NM23-H1 and, in frame,
the complete NM23-H2 protein (Fig. 1C).
Expression analysis of NM23-LV
NM23-H1 and-H2 are highly expressed in neuroblastoma
tumors and cell lines [12]. We analyzed the cDNA of two
neuroblastoma cell lines for the presence of NM23-LV
transcripts. NM23-LV was amplified using a forward primer in
the 5′-UTR of NM23-H1 and a reverse primer in the 3′-UTR ofNM23-H2. The sequence of the amplified product was identical
to the predicted NM23-LV mRNA.
The expression pattern of the NM23-LV transcript was
analyzed by RT-PCR in a panel of human tissues and compared
to the expression of NM23-H1 and-H2 (Fig. 2). In line with
other reports, the NM23-H1 and-H2 genes are ubiquitously
expressed. Also, the NM23-LV transcript is ubiquitously
expressed, with reduced expression in lung and hardly any
expression in kidney (Fig. 2, top). In the same experiment, we
analyzed NM23 expression in eight neuroblastoma tumors.
They all showed a high expression of NM23-H1, NM23-H2, and
NM23-LV.
The sequence of NM23-LV predicts a protein of 33 kDa.
Antibodies against NM23-H1 and-H2 detect proteins of 17 and
33 kDa on Western blot. The17-kDa protein is monomeric
NM23. The 33-kDa protein could represent the NM23-LV
protein. To analyze whether the 33-kDa band indeed represents
NM23-LV, we made a HA-tagged NM23-LV construct. HA-
NM23-LV and NM23-LV were transiently transfected in
neuroblastoma cell line SHEP-21N. Analysis of the cell lysates
with an anti-HA antibody confirmed the expression of NM23-
LV (Fig. 3A). The size of the protein is approximately 33 kDa
and exactly coincides with the 33-kDa band recognized by the
antibodies for NM23-H1 and NM23-H2.
Since NM23-LV could barely be detected by RT-PCR
amplification in kidney (Fig. 2), we also transfected the
embryonal kidney cell line HEK293. Indeed, lysates of
HEK293 cells transfected with empty vector did not show a
33-kDa NM23-LV band with an antibody to NM23-H2 (Fig.
3B, lane 3). However, after transient transfection with HA-
NM23-LV, a clear 33-kDa band is seen (Fig. 3B, lane 1). The
anti-NM23-H2 antibody detects an additional fragment of
approximately 20 kDa in both NM23-LV-and HA-NM23-LV-
transfected cells. Since this band is absent in empty-vector-
transfected cells, it most likely represents a degradation product
of NM23-LV. Together, these experiments strongly indicate that
the endogenous 33-kDa band seen in neuroblastomas but not in
HEK 293 cells represents the endogenous NM23-LV protein.
The cellular localization of the NM23-LV protein was
studied in SHEP-21N cells. HA-NM23-LV was transiently
transfected and the expression was analyzed by immunofluo-
rescence with a HA antibody (Fig. 3C, top). The expression was
compared to staining of endogenous NM23-H1 and NM23-H2
protein using specific polyclonal antibodies (Fig. 3C, middle
and bottom). The expression pattern of NM23-LV was similar
to that of NM23-H1 and-H2. The proteins are predominantly
localized in the cytoplasm, with perinuclear localization. All
three proteins are faintly expressed in the nucleus, but are
completely absent from the nucleoli.
Discussion
During evolution, the single NM23 gene was duplicated,
leading to at least eight members in mammals. The expression
and function of the members of the NM23 gene-family have
diverged. For instance, NM23-H4 is ubiquitously expressed but
located in mitochondria [29,30], whereas NM23-H5 expression
Fig. 1. Identification of NM23-LV. (A) Analysis of the genomic position of all NM23-H1 and NM23-H2 transcripts by the TranscriptView application. The NM23
cluster on chromosome 17q21.3 (chr17: 46.585.918–46.604.103 data based on hg17, UCSC http://genome.ucsc.edu/) is shown. The EST sequences are aligned along
the genomic sequence. The boldface dark green lines indicate the sequences found in the ESTs and mRNAs and represent exon sequences. They are connected by thin
light green lines, which indicate the intron sequences. Transcription goes from left to right. The reference sequences (RefSeq) are aligned at the bottom. (B) Zoom-in
view of the NM23-H1 and-H2 region. Note that the EST sequences aligning with both NM23 genes lack the last exon of NM23-H1 and the first exon of NM23-H2. The
predicted NM23-LV is indicated in red. (C) Predicted transcript and translation of NM23-LV. The sequences derived from NM23-H1 have a yellow background and
sequences derived from NM23-H2 have a blue background. The positions of the introns are indicated by gray arrowheads above the sequence.
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LV transcript, an alternative path toward a possible functional
divergence of the NM23 genes emerges. The NM23-LV
transcript is not encoded by a separate gene, but is the result
of read-through transcription from the NM23-H1 promoterfusing the NM23-H1 and-H2 transcripts. Subsequent alternative
splicing results in the skipping of NM23-H1 exon 5 and NM23-
H2 exon 1 and a novel mRNA encoding the NM23-LV protein.
The NM23-LV read-through transcript is not without
precedent. We used the TranscriptView application to determine
Fig. 3. Expression of the NM23-LV protein. (A, B) SHEP-21N cells (A) or HEK293 cells (B) were transfected with HA-NM23-LV, NM23-LV, or empty vector
(indicated above the lanes). After 24 h, the cell lysates were analyzed onWestern blot. The antibodies used are indicated on the right. Black arrow indicates the position
of NM23-LV; white arrow indicates the position of NM23-H1 or-H2. (C) SHEP-21N cells were grown on coverslides and transfected with HA-NM23-LV. After 48 h,
the cells were stained with anti-HA. Slides with untransfected cells were stained with anti-NM23-H1 or anti-NM23-H2.
Fig. 2. NM23-LV, NM23-H1, and NM23-H2 expression in tissues and neuroblastoma tumors. The NM23-LV mRNAwas amplified by RT-PCR with a forward primer
in NM23-H1 and a reverse primer in NM23-H2. The analyzed tissues are indicated above the lanes. The expression of NM23-LV was compared to the expression of
NM23-H1 and NM23-H2. The first lane is the DNA marker.
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neighboring genes. We previously defined transcriptional units
(TUs) as clusters of overlapping EST and mRNA alignments
[32]. If a fusion transcript of two different genes exists, such a
TU would overlap with more than one gene of the reference
sequence data set. We have analyzed all 41.919 TUs for the
presence of multiple gene identifiers and found 582 candidates.
Visual inspection in TranscriptView showed that the majority of
these candidates did not represent fusion transcripts. Finally, we
identified 65 gene pairs in which read-through transcription
could indeed exist. This showed that this phenomenon is quite
rare. Eleven of the 65 read-through transcripts have been
described in the literature, either as alternative transcripts of one
of the involved genes (i.e., MGC2408-ECE2 [33], TRIM6-
TRIM34 [34]) or as actual fusion transcripts (i.e., Kua-UEV
[35], PALM-AKAP2 [36], TWE-PRIL [37], S-ALF [38],
MASK-BP3 [39], and DEC205-DCL1 [40]). There is evidence
that read-through transcription is regulated and is not a
transcriptional error. The DEC205-DCL1 fusion transcript is
highly expressed in Hodgkin's lymphoma cell lines with
DEC205 expression [40]. However, DEC205-DCL1 is not
detected in other myloid cell lines, which do highly express
DEC205.
The biological effect of the read-through transcripts can
occur at RNA and protein levels. Transcription initiation factor
ALF is exclusively expressed in testis. Read-through transcrip-
tion from the stonin 2 gene results in a wide expression of the
SALF protein, which is a fusion of stonin B and, in frame, the
ALF protein [38]. Although, in vitro, the SALF can still be a
part of the transcription initiation complex, the influence of the
stonin protein is unknown. In the case of Kua-UEV [35] and
TWE-PRIL [37], the fusion proteins lead to altered function of
the proteins, due to relocation in the cell. The Kua protein, with
unknown function, is fused in frame with the UEV protein, a
regulator of ubiquitinylation. The resulting Kua-UEV protein is
located in the cytoplasm, instead of the normal nuclear UEV1
localization. The TWE-PRIL transcript fuses two genes
encoding TNF ligand family members [37]. The resulting
protein translocates the normally secreted APRIL protein
directly to the membrane by fusion with the transmembrane
part of the TWEAK protein. In line with these examples, the
NM23-LV protein fuses the NM23-H1 and NM23-H2 proteins
in frame. However, in the latter case the fused proteins
originally have similar functions and are part of the same
NDPK complex.
The NDPK enzyme consists of a homohexamer or hetero-
hexamer of NM23-H1 and NM23-H2 [1]. The structure of the
hexamer can be viewed as a dimer of two NM23 trimers or a
trimer of three NM23 dimers [41]. The NM23-LV protein
contains part of NM23-H1 and the entire NM23-H2 protein.
However, the NM23-LV protein is unlikely to function as a
simple NM23-H1/H2 dimer. The NM23 monomers consist of
four β-sheets, each followed by an α-helix. The structure of the
kinase is based on folding of the β-sheets in an antiparallel
orientation [42]. The normal structure of the NM23 dimer con-
sists of eight β-sheets and α-helixes. The NM23-LV transcript
lacks exon 5 of the NM23-H1 gene, which encodes one β-sheetand one α-helix. Therefore, the NM23-LV protein has only
seven β-sheets, which cannot adapt to the antiparallel β-
sheet formation. The Nm23-LV protein therefore probably
disturbs the normal hexamer formation. In addition, exon 5
contains His118, which is part of the active site motif for
NDPK [1].
Evidence that the NM23 proteins have functions beyond
NDPK in tumors has accumulated. In melanoma and prostatic
carcinoma ,the mRNA expression level of NM23-H1 is
correlated with tumor progression, not the NDPK activity [8].
This suggests that NM23-H1 has a function, separate from
NDPK, that is involved in tumorigenesis. With the identifica-
tion of NM23-LV, an alternative possibility emerges. The
NM23-LV transcript, which is derived from the same promoter
as NM23-H1, will also be reduced in these tumors and might
contribute to tumorigenesis. We showed that in neuroblastoma
tumors, which have increased NM23 expression, not only
NM23-H1, but also NM23-LV, is highly expressed.
In neuroblastoma cells, the NM23-H1,-H2, and-LV proteins
show the same cellular localization. The proteins were
predominantly located in the cytoplasm, with some nuclear
expression, but were completely absent from the nucleoli. This
is in contrast to breast carcinoma cells, which show localization
of NM23-H2 in the nucleoli [19]. Also, the plasma membrane
localization observed in breast carcinoma cells is absent in
neuroblastoma cells. In neuroblastomas high levels are
correlated with a poor prognosis, but in breast tumors they are
correlated with a good prognosis. The different localization of
NM23 proteins based on the cell type studied might indicate the
difference in function and tumorigenic potential.
In conclusion, NM23 proteins have a wide variety of
functions, ranging from NDP kinases to regulation of cell
growth, differentiation, and metastatic potential. During
evolution, the NM23 genes have multiplied, resulting in eight
family members with possibly more specialized functions.
Here, we identified a novel NM23 protein, NM23-LV, which is
derived from a rare genomic phenomenon. The NM23-LV is
encoded by the NM23-H1 and-H2 genes and results from read-
through transcription and alternative spicing. The newly
identified NM23-LV might further add to the functional
diversification of the NM23 family.
Materials and methods
TransciptView
TranscriptView is a Web-based visualization tool for alignments of all
mRNA and EST sequences to the human genome. The alignments to the
genomic sequence were generated by the BLAT algorithm and taken from the
genome browser at UCSC (http://genome.ucsc.edu/). Unlike the genome
browser at UCSC, TranscriptView displays the alignments in different color
schemes based on various selection criteria (such as orientation or tissue). In
the current article, the orientation of alignments was used, such that genes
oriented 5′ to 3′ on the positive strand of the genome are depicted in shades
of green, whereas those that are present on the negative strand are depicted in
shades of red. Intronic sequences have transparent colors and exons are full
colored. In addition to the alignments, more information can be obtained by
hovering over the aligned sequence. The program can be accessed at http://
bioinfo.amc.uva.nl/human-genetics/transcriptview/.
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The SHEP-21N cells were cultured in RPMI and the HEK293 cells were
cultured in D-MEM. Both media were supplemented with 10% FCS, 2 mM
glutamine, 50 U/ml penicillin, and 50 U/ml streptomycin.
RT-PCR
Random-primed cDNAwas made of 2 μg total RNA in a 30-μl reaction: 50
mM KCl, 10 mM Tris, pH 8.3, 0.001% gelatin, 1.5 mM MgCl2, 1 mM each
dNTP, 0.0625 units pd(N)6 (Amersham Biosciences, Buckinghamshire, UK), 20
units RNasin (Promega Biosciences, San Luis Obispo, CA), and 200 units
Superscript Reverse Transcriptase (Invitrogen, Carlsbad, CA). The reaction was
incubated at RT for 10 min followed by 45 min at 42°C.
One microliter cDNAwas used in a 25-μl PCR: 50 mM KCl, 10 mM Tris,
pH 8.3, 0.001% gelatin, 1.5 mM MgCl2, 0.2 mM each dNTP, 25 ng per primer,
0.5 units Taq DNA polymerase (Roche Diagnostics, Mannheim, Germany). The
reactions were initially denaturated for 5 min at 95°C, followed by 35 cycles of
30 s at 95°C, 30 s at 55°C, and 1 min at 72°C, and finally extension for 5 min at
72°C. The primers used for NM23-H1 are NM23H1for (5′-GCCGGAGTT-
CAAACCTAAG) and NM23H1rev (5′-GGAAGGAGGGGAAATGGATG), the
primers for NM23-H2 are NM23H2for (5′-CACCTTCATCGCCATCAAG) and
NM23H2rev (5′-AGAATGATCAATCCTGTTGCC), and the primers for
NM23-LV are NM23H1for and NM23H2rev.
Plasmids
The NM23-LV expression vectors were constructed by amplification of
NM23-LV from SHEP-21N cDNA with adaptor primers NM23H1for (5′-
TATATAGGATCCATGGCCAACTGTGAGCGTAC) and NM23H2rev
(TATATGAATTCGGAGACTGCTGTTGTGTCCA). The amplified product
was digested with BamHI and EcoRI and cloned in pcDNA3.1/Zeo (Invitrogen),
resulting in pNM23-LV. The product was also cloned in pHA (pcDNA3.1/Zeo,
with HA tag and BamHI site), resulting in pHA-NM23-LV. The inserts were
confirmed by bidirectional sequencing.
Western blot analysis
Cells were grown to 25% confluency in a 6-cm plate. Eight micrograms
plasmid DNA was diluted in 0.5 ml OptiMEM (Invitrogen) and 8 μl DAC-30
(Eurogentec, Seraing, Belgium) was diluted in 0.5 ml OptiMEM. The DNA mix
was added to the DAC-30 mix and incubated at RT for 25 min. The medium of
the cells was replaced by 3.5 ml fresh complete medium and the DNA/DAC30
mix was added dropwise to the cells.
After 24 h, cell extracts were made by scraping the cells in lysis buffer (50
mM Tris, pH 7.4, 0.1 M NaCl, 10% glycerol, 1% NP-40, 2 mM MgCl2). Ten
micrograms protein was separated on 15% SDS–PAGE gels and transferred to
Immobilon-P membrane (Millipore, Billerica, MA). The dry Western blots were
directly incubated for 1 h with primary polyclonal anti-nm23-H1 or anti-nm23-
H2 [19] 5000 times diluted in AbDil2.5 [2.5% nonfat dry milk in TBS-Tw (150
mM NaCl, 25 mM Tris, pH 7.4, 0.1% Tween)]. The filters were washed with
TBS-Tw and incubated with peroxidase-conjugated anti-rabbit (Amersham)
5000 times diluted in AbDil2.5. After being washed with TBS-Tw, the signal
was detected with the ECL KIT (Amersham).
For HA detection, the filter was blocked for 1 h with Abdil5 [5% nonfat dry
milk in phosphate-buffered saline (PBS)]. The mouse monoclonal anti-HA
(clone 12CA5, Roche) was diluted 5000 times in Abdil5 and washed with TBT
(0.5 M NaCl, 50 mM Tris, pH 7.5, 0.02% Triton X-100). Secondary peroxidase-
conjugated anti-mouse (Amersham) was 5000 times diluted in AbDil5 and
washed with TBT, followed by ECL detection.
Immunofluorescence detection
Cells were grown to 25% confluency on glass slides in 6-well plates. Five
micrograms of plasmid DNA (in 0.5 ml OptiMEM) was added to 5 μl DAC-30
(in 0.5 ml OptiMEM). After a 25-min incubation, the DNA/DAC-30 mix wasdropwise added to the 1.5 ml fresh complete medium. The medium was
refreshed 18 h posttransfection. For endogenous expression analysis, untrans-
fected cells were grown on glass slides.
Forty-eight hours posttransfection, the cells were fixed with 4% parafor-
maldehyde/PBS for 25 min. The cells were permeabilized with PBS/0.05%
Triton X-100. After being washed three times with PBS/TX (PBS, 0.01% Triton
X-100), the slides were blocked for 30 min in Abdil (PBS, 0.01% Triton X-100,
1% BSA). The primary antibodies (anti-NM23-H1, anti-NM23-H2, anti-HA)
were 100 times diluted in Abdil and incubated for 30 min. The slides were
washed four times with PBS/TX. The secondary antibodies, TRITC-conjugated
anti-rabbit or anti-mouse (Sigma), were diluted 100 times in Abdil and incubated
for 30 min. After being washed three times with PBS, the slides were rinsed with
H2O, dried, and mounted in Vectashield (Vector Laboratories, Burlingame, CA).
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